MPEP § 2413.01(d) — The “Sequence Listing XML” Must Contain a DOCTYPE Declaration (Annotated Rules)
§2413.01(d) The “Sequence Listing XML” Must Contain a DOCTYPE Declaration
This page consolidates and annotates all enforceable requirements under MPEP § 2413.01(d), including statutory authority, regulatory rules, examiner guidance, and practice notes. It is provided as guidance, with links to the ground truth sources. This is information only, it is not legal advice.
The “Sequence Listing XML” Must Contain a DOCTYPE Declaration
This section addresses The “Sequence Listing XML” Must Contain a DOCTYPE Declaration. Primary authority: 37 CFR 1.831(b) and 37 CFR 1.833. Contains: 2 requirements, 1 permission, and 1 other statement.
Key Rules
Sequence Listing Format
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b). Formatting representations of XML (eXtensible Markup Language) elements in this section appear different than shown in Standard ST.26, which may be accessed at: www.wipo.int /export/sites/www/standards/en/pdf/03-26-01.pdf.]
(b) The “Sequence Listing XML” presented in accordance with paragraph (a) of this section must further:
- *****
- (2) Comply with the requirements of WIPO Standard ST.26 to include:
- *****
- (ii) A document type (DOCTYPE) declaration as defined in paragraph 39(b) of WIPO Standard ST.26;
WIPO Standard ST.26, paragraph 39(b), specifies that the second line of the XML instance must contain the document type (DOCTYPE) declaration, which is:
Sequence Listing Content
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b). Formatting representations of XML (eXtensible Markup Language) elements in this section appear different than shown in Standard ST.26, which may be accessed at: www.wipo.int /export/sites/www/standards/en/pdf/03-26-01.pdf.]
Citations
| Primary topic | Citation |
|---|---|
| Sequence Listing Content Sequence Listing Format | 37 CFR § 1.831(b) |
Source Text from USPTO’s MPEP
This is an exact copy of the MPEP from the USPTO. It is here for your reference to see the section in context.
Official MPEP § 2413.01(d) — The “Sequence Listing XML” Must Contain a DOCTYPE Declaration
Source: USPTO2413.01(d) The “Sequence Listing XML” Must Contain a DOCTYPE Declaration [R-01.2024]
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b). Formatting representations of XML (eXtensible Markup Language) elements in this section appear different than shown in Standard ST.26, which may be accessed at: www.wipo.int /export/sites/www/standards/en/pdf/03-26-01.pdf.]
37 CFR 1.833 Requirements for a “Sequence Listing XML” for nucleotide and/or amino acid sequences as part of a patent application filed on or after July 1, 2022.
-
*****
- (b) The “Sequence Listing XML” presented in
accordance with paragraph (a) of this section must further:
-
*****
- (2) Comply with the requirements of WIPO
Standard ST.26 to include:
-
*****
- (ii) A document type (DOCTYPE) declaration as defined in paragraph 39(b) of WIPO Standard ST.26;
-
-
-
*****
WIPO Standard ST.26, paragraph 39(b), specifies that the second line of the XML instance must contain the document type (DOCTYPE) declaration, which is:
<!DOCTYPE ST26SequenceListing PUBLIC “-//WIPO//DTD Sequence Listing 1.3//EN” “ST26SequenceListing_V1_3.dtd”>